Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
April 15, 2014
Patent Application Number
13203418
Date Filed
February 26, 2010
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention provides materials and methods relating to antibodies specific for a soluble form of CTLA-4 (sCLTA-4). Such antibodies have been shown to have a strong boosting effect on antigen-specific human immune responses.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
